The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 332:754 March 16, 1995 Number 11
NextNext

Skin Cancer Occurring 10 Years after the Extravasation of Doxorubicin

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
To the Editor: The potential for cancer to develop at the sites of chronic wounds was described in 1828 by Marjolin.1 We report a skin cancer in a 58-year-old woman at the site of the extravasation of doxorubicin, 10 years after the drug was administered.

The patient underwent total gastrectomy for adenocarcinoma in 1982. The tumor involved the serous membrane of the stomach and two lymph nodes. Adjuvant chemotherapy consisting of doxorubicin (50 mg per square meter of body-surface area on day 1), mitomycin (10 mg per square meter on day 2), and fluorouracil (400 mg per square meter on . . . [Full Text of this Article]

References



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.